Home / Recalls / Cantrell Drug Company / D-0204-2017

D-0204-2017 Class II Terminated

Recalled by Cantrell Drug Company — Little Rock, AR

Recall Details

Product Type: Drugs
Report Date: December 21, 2016
Initiation Date: November 18, 2016
Termination Date: April 29, 2020
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 9859 syringes

Product Description

Succinylcholine Chloride 200 mg/10 mL Injection Solution 10 mL (20 mg/mL) ,Single-Dose Syringe Injection Solution, For Slow IV Use Only ,Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207, NDC 52533-067-12

Reason for Recall

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Distribution Pattern

Nationwide

Code Information

Lot: 169262 BUD: 1/8/2017, Lot: 169812 BUD: 1/19/2017

Other recalls by Cantrell Drug Company

D-1063-2017 Class II — Ephedrine Sulfate Injection Solution 1 mL, 50 mg/1 mL (50 mg/mL) Single-Dose Sy (July 14, 2017)
D-1064-2017 Class II — Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 50 mg/5 mL (10 mg/mL) Single-Do (July 14, 2017)
D-1073-2017 Class II — Diltiazem HCl 125 mg in 5% Dextrose 125 mL Single-Dose- Bag, Rx Only, Cantrell (July 14, 2017)
D-1067-2017 Class II — Glycopyrrolate Injection Solution, 1 mL 0.2 mg/1 mL (0.2 mg/mL) Single-Dose Syri (July 14, 2017)
D-1061-2017 Class II — Ephedrine Sulfate in 0.9% Sodium Chloride 10 mL, 50 mg/10 mL (5 mg/mL) Single-Do (July 14, 2017)
D-1070-2017 Class II — Norepinephrine Bitartrate 8 mg Added to 0.9% Sodium Chloride 250 mL (32 mcg per (July 14, 2017)
D-1075-2017 Class II — Sodium Bicarbonate 8.4% Injection Solution 50 mL, 50 mEq (1mEq/mL) Single-Dose S (July 14, 2017)
D-1068-2017 Class II — Succinylcholine Chloride Injection Solution 10 mL, 200 mg/10 mL (20 mg/mL) Singl (July 14, 2017)
D-1071-2017 Class II — Norepinephrine Bitartrate 16 mg Added to 0.9% Sodium Chloride 250 mL (64 mcg per (July 14, 2017)
D-1062-2017 Class II — Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 25 mg/5 mL (5 mg/mL) Single-Dose (July 14, 2017)